Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Aug 2015

Kamel Azza M, Ebid Gamal T A, Moussa Heba S

Abstract excerpt

N-Acetyltransferases (NAT) have been known to modify the risk to a variety of solid tumors. However, the role of NAT2 polymorphism in risk susceptibility to childhood acute lymphoblastic leukemia (ALL) is still not well known. We performed a case-control study to determine if the common NAT2 polymorphisms play a role in altering susceptibility to pediatric ALL. DNA of 92 pediatric ALL patients and 312 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Arylamine N-Acetyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Child, Preschool

Share to Genetic Association Studies

Share to Infant

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Risk Factors

Source

Identifiers

PMID: 25804798
DOI: 10.1007/s13277-015-3320-7

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.PMID 25804798Read ↗

Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.Semantic proximity Read ↗

Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil.Semantic proximity Read ↗

Relationship between NAT2 polymorphisms and onset risk of acute leukemia: a systematic review and meta-analysis.Semantic proximity Read ↗

Genetic susceptibility to childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study.Semantic proximity Read ↗

Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study.Semantic proximity Read ↗

CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.Semantic proximity Read ↗

A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.Semantic proximity Read ↗

N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.Semantic proximity Read ↗

Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.Semantic proximity Read ↗

Genotype-Environment Interaction Analysis of NQO1, CYP2E1, and NAT2 Polymorphisms and the Risk of Childhood Acute Lymphoblastic Leukemia: A Report From the Mexican Interinstitutional Group for the Identification of the Causes of Childhood LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.